RxDoctor Payments Data

Oscar Vazquez, MD

Orthopaedic Surgery · Hackensack, NJNPI 1063608875

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (52.2%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Smith+Nephew at 36.9% of the total. Reporting peaked in 2021 at $22,421 and has fallen 70.1% since, to $6,698 in 2025. Among orthopaedic surgery clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$87,396in general payments, 2019–2025

Across 350 payments — averaging $249.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$32K
  • Depuy Synthes Products, Inc.$9K
  • Anika Therapeutics, Inc.$7K
  • Acumed LLC$7K
  • Amgen$5K
  • Ossio Inc$5K
  • plus $23K from 31 others
$45,436in research payments, 2019–2025

Across 25 payments — averaging $1817.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Integra Lifesciences Corporation$18K
  • Linvatec Corporation$15K
  • Zimmer Biomet$6K
  • Smith+Nephew$6K
$720,757in ownership & investment interests, 2019–2025

Across 5 payments — averaging $144,151 each. An ownership or investment interest held by the physician or an immediate family member.

  • Zurimed Technologies Inc.$582K
  • Lazurite Inc.$75K
  • Overture Orthopaedics$64K

What the payments were for

  • Consulting fees$45,60452%
  • Speaking & faculty fees$16,14418%
  • Travel & lodging$6,5087%
  • Food & beverage$16,73419%
  • Education$2,1392%
  • Gifts$670%
  • Entertainment$190%
  • Other$1810%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$87,396 in reported general payments places this provider in the 90th percentile of 587 orthopaedic surgery providers in New Jersey.

See all orthopaedic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$893,294
Medicare patients
743
Services billed
8,605

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam1,285$4,262
Diclofenac Sodium ErDiclofenac Sodium173$4,258
Celecoxib123$1,795
Naproxen110$978
Methylprednisolone97$639
Cyclobenzaprine Hcl108$418
Diclofenac Sodium14$247
Tramadol Hcl69$186
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen40$170
Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen15$79
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13$60
Ibuprofen13$44

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Hackensack

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →